Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	dendrite development	NEDD4L MAP1A NUMBL SYNE1 EZH2 PDLIM5 STRN HECW2 SIPA1L1 TET1 PRMT3 TRAK2 SDK1 EPHA4	5.38e-07	335	165	14	GO:0016358
GeneOntologyBiologicalProcess	dendrite morphogenesis	NEDD4L NUMBL SYNE1 PDLIM5 HECW2 SIPA1L1 TET1 PRMT3 TRAK2 EPHA4	4.55e-06	198	165	10	GO:0048813
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	NEDD4L NRCAM MAP1A ATG7 NUMBL MYCBP2 SYNE1 SLITRK1 KIF20B PDLIM5 KANK1 PLAA HECW2 SIPA1L1 TET1 DOCK7 MACF1 PRMT3 TRAK2 EPHA4	9.18e-06	819	165	20	GO:0120039
GeneOntologyBiologicalProcess	cell projection morphogenesis	NEDD4L NRCAM MAP1A ATG7 NUMBL MYCBP2 SYNE1 SLITRK1 KIF20B PDLIM5 KANK1 PLAA HECW2 SIPA1L1 TET1 DOCK7 MACF1 PRMT3 TRAK2 EPHA4	1.04e-05	826	165	20	GO:0048858
GeneOntologyBiologicalProcess	neuron projection morphogenesis	NEDD4L NRCAM MAP1A ATG7 NUMBL MYCBP2 SYNE1 SLITRK1 KIF20B PDLIM5 PLAA HECW2 SIPA1L1 TET1 DOCK7 MACF1 PRMT3 TRAK2 EPHA4	2.37e-05	802	165	19	GO:0048812
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	NEDD4L NRCAM MAP1A ATG7 NUMBL MYCBP2 SYNE1 TPRN SLITRK1 PDLIM5 HECW2 SIPA1L1 TET1 DOCK7 MACF1 PRMT3 TRAK2 EPHA4	3.21e-05	748	165	18	GO:0048667
GeneOntologyBiologicalProcess	neuron projection development	NEDD4L NRCAM MAP1A ATG7 NUMBL MYCBP2 SYNE1 TPRN EZH2 SLITRK1 KIF20B PDLIM5 STRN KANK1 PLAA OTOGL HECW2 SIPA1L1 TET1 DOCK7 MACF1 PRMT3 TRAK2 SDK1 EPHA4	3.27e-05	1285	165	25	GO:0031175
GeneOntologyBiologicalProcess	neuron development	MYT1L DRD1 NEDD4L NRCAM MAP1A ATG7 NUMBL MYCBP2 SYNE1 TPRN EZH2 SLITRK1 KIF20B PDLIM5 STRN KANK1 PLAA OTOGL HECW2 SIPA1L1 TET1 DOCK7 MACF1 PRMT3 TRAK2 SDK1 EPHA4	3.83e-05	1463	165	27	GO:0048666
GeneOntologyBiologicalProcess	double-strand break repair via synthesis-dependent strand annealing	RAD51C RAD52 FANCM	4.08e-05	9	165	3	GO:0045003
GeneOntologyBiologicalProcess	DNA recombination	RAD51C RAD52 RAD18 FANCM EZH2 INO80D THAP9 MEI4 RMI1 PPP4R2 PAXIP1 ATM	4.25e-05	368	165	12	GO:0006310
GeneOntologyBiologicalProcess	protein localization to M-band	ANK2 OBSCN	6.36e-05	2	165	2	GO:0036309
GeneOntologyBiologicalProcess	facultative heterochromatin formation	EED BEND3 EZH2 RESF1 TASOR	7.76e-05	55	165	5	GO:0140718
GeneOntologyBiologicalProcess	regulation of receptor recycling	CHMP5 LDLR TBC1D16 PCSK9	1.05e-04	31	165	4	GO:0001919
GeneOntologyBiologicalProcess	regulation of dendrite morphogenesis	NEDD4L NUMBL SYNE1 HECW2 SIPA1L1 EPHA4	1.80e-04	103	165	6	GO:0048814
GeneOntologyBiologicalProcess	polyuridylation-dependent mRNA catabolic process	TUT4 DIS3L2	1.90e-04	3	165	2	GO:1990074
GeneOntologyBiologicalProcess	regulation of dendrite development	NEDD4L NUMBL SYNE1 EZH2 HECW2 SIPA1L1 EPHA4	2.08e-04	150	165	7	GO:0050773
GeneOntologyBiologicalProcess	action potential	USP53 DRD1 NEDD4L ANK2 NRCAM AKAP9 SCN7A KCNS3	2.20e-04	201	165	8	GO:0001508
GeneOntologyBiologicalProcess	cell morphogenesis	NEDD4L NRCAM MAP1A ATG7 NUMBL MYCBP2 SYNE1 TPRN LARP4 SLITRK1 KIF20B PDLIM5 KANK1 PLAA HECW2 SIPA1L1 TET1 DOCK7 MACF1 PRMT3 TRAK2 EPHA4	2.21e-04	1194	165	22	GO:0000902
GeneOntologyBiologicalProcess	negative regulation of sodium ion transmembrane transporter activity	NEDD4L HECW2 PCSK9	2.61e-04	16	165	3	GO:2000650
GeneOntologyBiologicalProcess	negative regulation of sodium ion transmembrane transport	NEDD4L HECW2 PCSK9	3.15e-04	17	165	3	GO:1902306
GeneOntologyCellularComponent	PCSK9-LDLR complex	LDLR PCSK9	6.19e-05	2	165	2	GO:1990666
HumanPheno	Supravalvular aortic stenosis	LDLR DOCK7 GTF2IRD2 LTBP1 PCSK9	1.42e-05	30	55	5	HP:0004381
HumanPheno	Sudden cardiac death	ANK2 SYNE1 CPT1A LDLR AKAP9 PPA2 GTF2IRD2 PCSK9	2.19e-05	112	55	8	HP:0001645
HumanPheno	Cardiac arrest	ANK2 SYNE1 CPT1A LDLR TGFBR2 AKAP9 PPA2 GTF2IRD2 PCSK9	4.16e-05	159	55	9	HP:0001695
HumanPheno	Sudden death	ANK2 SYNE1 CPT1A LDLR AKAP9 PPA2 GTF2IRD2 PCSK9	6.80e-05	131	55	8	HP:0001699
Domain	RII_binding_1	AKAP3 AKAP12 AKAP13	5.98e-06	5	159	3	PF10522
Domain	RII_binding_1	AKAP3 AKAP12 AKAP13	5.98e-06	5	159	3	IPR018459
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	USP34 NOL4 NR2C1 MYCBP2 BEND3 ICE1 NUP214 ANKHD1 BIRC6 KIF20B NCOR1 RESF1 TET1 DOCK7 TMF1 ANKRD17 TASOR OBI1	2.06e-12	418	166	18	34709266
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	NEDD4L NRCAM SYNE1 KIAA0232 DLGAP4 BEND3 NUP214 DCAF5 KANK1 AKAP9 SIPA1L1 DOCK7 MACF1 DISP2 RIMBP2 TRAK2	1.41e-10	407	166	16	12693553
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP53 KIF21B USP34 WAPL HECTD4 ICE1 ANKHD1 CTTNBP2NL ADCY9 HECW2 TET1 ANKRD17 PCNX1 SCAF11 PPIP5K2 HPS5 IGSF3	7.99e-10	529	166	17	14621295
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	KIF21B NEDD4L ANK2 NRCAM TRAF3IP1 NUMBL MYCBP2 SYNE1 DLGAP4 HECTD4 AKAP12 NCOR1 STRN AKAP9 KIAA1217 SIPA1L1 DOCK7 ANKRD17 MACF1 KIF4B RIMBP2 EPHA4	1.41e-09	963	166	22	28671696
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	USP34 NR2C1 TUT4 WAPL MYCBP2 AKAP3 ICE1 NUP214 LARP4 BIRC6 ADCY9 PDLIM5 PIKFYVE KANK1 TMF1 AKAP13 UQCRH PPIP5K2 TASOR	2.68e-09	733	166	19	34672954
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	USP34 WAPL MYCBP2 CPT1A CTTNBP2NL STRN SUPT5H HECW2 SIPA1L1 ANKRD17 TASOR	6.87e-09	212	166	11	33853758
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	MYT1L USP34 MYCBP2 SYNE1 KIAA0232 BIRC6 ADCY9 SIPA1L1 MACF1 PCNX1 HPS5	1.27e-08	225	166	11	12168954
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	USP34 RAD18 MAP1A TPRN TACC2 KIF20B PIKFYVE RMI1 NCOR1 STRN RESF1 SUPT5H PPP4R2 KIAA1217 MACF1 OBI1	2.65e-08	588	166	16	38580884
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	USP53 NEDD4L NUMBL MYCBP2 KIAA0232 CDCA2 RESF1 AKAP9 KIAA1217 SIPA1L1 TET1 DOCK7 ANKRD17 MACF1 AKAP13 PDCL PPIP5K2 OBI1 EDRF1	3.51e-08	861	166	19	36931259
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	USP34 MYCBP2 HECTD4 OBSCN ICE1 NUP214 ANKHD1 BIRC6 LDLR ADCY9 ANO8 TBC1D16 PIKFYVE NCOR1 PPA2 PAXIP1 PCNX1 AKAP13 DISP2 BCAM IGSF3	8.05e-08	1105	166	21	35748872
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	MYT1L TRPM6 USP34 RAD18 WAPL OBSCN TACC2 ANKHD1 LDLR DCAF5 AKAP12 RESF1 PLAA PPP4R2 SIPA1L1 TET1 ANKRD17 MACF1 TASOR UTP14C	2.69e-07	1084	166	20	11544199
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	RAD52 USP34 NR2C1 RAD18 CHMP5 BEND3 ICE1 FANCM NCAPG2 KIF20B WTAP RMI1 ATM	3.11e-07	453	166	13	29656893
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	USP34 NOL4 CAAP1 RAD18 TUT4 WAPL MAP1A TPRN BEND3 ANKHD1 TUBGCP5 INO80D LDLR DCAF5 ADCY9 RESF1 SIPA1L1 ANKRD17 MACF1 PDCL	4.24e-07	1116	166	20	31753913
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	USP34 MYCBP2 NOL6 BEND3 NUP214 XPO1 ANKHD1 LARP4 BIRC6 SUPT5H DOCK7 ANKRD17 MACF1 SCAF11 ATM	6.35e-07	653	166	15	22586326
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	NEDD4L ANK2 NRCAM MAP1A NUMBL MYCBP2 DLGAP4 ADCY9 SIPA1L1 MACF1 RIMBP2	9.91e-07	347	166	11	17114649
Pubmed	DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation.	TRAF3IP1 MAP1A SYNE1 ANKHD1	3.42e-06	22	166	4	12812986
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	MYT1L USP34 NR2C1 DCHS2 WAPL ANK2 NRCAM TRAF3IP1 MYCBP2 SYNE1 HECTD4 TUBGCP5 DCAF5 PDLIM5 CRYL1 SUPT5H SIPA1L1 MACF1 ATM ZNF292	3.65e-06	1285	166	20	35914814
Pubmed	Tagging genes with cassette-exchange sites.	EZH2 BIRC6 NCOR1 RESF1 PLAA TET1 MACF1 AKAP13 EPHA4 ZNF292	5.30e-06	335	166	10	15741177
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	MAP1A CTTNBP2NL SIPA1L1 DOCK7 MACF1 PRMT3 TRAK2 PDCL	7.96e-06	209	166	8	36779422
Pubmed	Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.	MYT1L ANK2 TRAF3IP1 SYNE1 RESF1 AKAP9 MACF1	8.62e-06	151	166	7	17043677
Pubmed	ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer.	USP53 EED EZH2	8.78e-06	9	166	3	29669287
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	ANK2 NRCAM MAP1A NUMBL SYNE1 DLGAP4 STRN SIPA1L1 MACF1	9.04e-06	281	166	9	28706196
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	USP53 RAD52 TUT4 NEDD4L ATG7 NUMBL MYCBP2 KIAA0232 CHMP5 HECTD4 OBSCN CPT1A LARP4 ANO8 KIAA1217 ANKRD17 MACF1 AKAP13 SCAF11 TAFA5 HPS5	9.29e-06	1489	166	21	28611215
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	TUT4 NEDD4L ANK2 NRCAM MAP1A MYCBP2 DLGAP4 TACC2 BIRC6 ANO8 STRN PLAA KIAA1217 SIPA1L1 PPA2 DOCK7 MACF1 IGSF3	9.42e-06	1139	166	18	36417873
Pubmed	Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	DLGAP4 ICE1 USP20 PIKFYVE PCNX1 HPS5	9.96e-06	102	166	6	10231032
Pubmed	Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	SYNE1 THSD7B ASXL3 TET1 DOCK7 DISP2	9.96e-06	102	166	6	11214970
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	EED MYCBP2 ICE1 DCAF10 ASXL3 MACF1 AKAP13 C1orf94 OBI1 REV1	1.02e-05	361	166	10	26167880
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	CAAP1 TUT4 MAP1A MYCBP2 CHMP5 ANKHD1 LARP4 PDLIM5 AKAP12 DOCK7 ANKRD17 MACF1 AKAP13 ZNF292	1.09e-05	724	166	14	36232890
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	RAD18 WAPL TRAF3IP1 SYNE1 TACC2 NUP214 XPO1 TUBGCP5 CTTNBP2NL AKAP12 RMI1 STRN KANK1 PLAA DCAF10 KIF4B ATM OBI1	1.14e-05	1155	166	18	20360068
Pubmed	A conserved acetylation switch enables pharmacological control of tubby-like protein stability.	RAD18 NUMBL BEND3 BIRC6 DCAF5 STRN PDCL ZNF292	1.27e-05	223	166	8	33187986
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	USP34 CAAP1 KIAA0232 DLGAP4 NCAPG2 LDLR ADCY9 TGFBR2 PPP4R2 PPA2 TMF1 MACF1 LTBP1 ATM BCAM SMIM1 OBI1	1.42e-05	1061	166	17	33845483
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	RAD18 EED BEND3 NUP214 CPT1A FANCM EZH2 INO80D LDLR WTAP CDCA2 RMI1 NCOR1 SUPT5H PAXIP1 WDR89 SCAF11 UQCRH TASOR	1.47e-05	1294	166	19	30804502
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	WAPL MYO19 NOL6 EZH2 ANKHD1 NCAPG2 SUPT5H DOCK7 ANKRD17 AKAP13 PPIP5K2 HPS5 TASOR	1.60e-05	650	166	13	38777146
Pubmed	Polycomb EZH2 controls self-renewal and safeguards the transcriptional identity of skeletal muscle stem cells.	EED EZH2 PAX7	1.71e-05	11	166	3	21498568
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	NOL4 CAAP1 NEDD4L MAP1A NUMBL MYCBP2 SYNE1 ARRDC5 HECTD4 XPO1 WTAP SUPT5H DOCK7 MACF1 ATM PPIP5K2 ZNF292	1.82e-05	1082	166	17	38697112
Pubmed	Patients With LDLR and PCSK9 Gene Variants Experienced Higher Incidence of Cardiovascular Outcomes in Heterozygous Familial Hypercholesterolemia.	LDLR PCSK9	2.26e-05	2	166	2	33533259
Pubmed	Effect of diet and genotype on the miRNome of mice with altered lipoprotein metabolism.	LDLR PCSK9	2.26e-05	2	166	2	37664585
Pubmed	PCSK9 acts as a chaperone for the LDL receptor in the endoplasmic reticulum.	LDLR PCSK9	2.26e-05	2	166	2	24144304
Pubmed	Mice Fed a High-Cholesterol Diet Supplemented with Quercetin-3-Glucoside Show Attenuated Hyperlipidemia and Hyperinsulinemia Associated with Differential Regulation of PCSK9 and LDLR in their Liver and Pancreas.	LDLR PCSK9	2.26e-05	2	166	2	29396908
Pubmed	Antagonism of secreted PCSK9 increases low density lipoprotein receptor expression in HepG2 cells.	LDLR PCSK9	2.26e-05	2	166	2	19224862
Pubmed	Serum proprotein convertase subtilisin/kexin type 9 and cell surface low-density lipoprotein receptor: evidence for a reciprocal regulation.	LDLR PCSK9	2.26e-05	2	166	2	23690465
Pubmed	Hypercholesterolemia Induced by a PCSK9 Gain-of-Function Mutation Augments Angiotensin II-Induced Abdominal Aortic Aneurysms in C57BL/6 Mice-Brief Report.	LDLR PCSK9	2.26e-05	2	166	2	27470509
Pubmed	Binding to the low-density lipoprotein receptor accelerates futile catalytic cycling in PCSK9 and raises the equilibrium level of intramolecular acylenzyme.	LDLR PCSK9	2.26e-05	2	166	2	19222187
Pubmed	New PCSK9 inhibitor miR-552-3p reduces LDL-C via enhancing LDLR in high fat diet-fed mice.	LDLR PCSK9	2.26e-05	2	166	2	33737240
Pubmed	Having excess levels of PCSK9 is not sufficient to induce complex formation between PCSK9 and the LDL receptor.	LDLR PCSK9	2.26e-05	2	166	2	24486405
Pubmed	CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway.	RASA4 RASA4B	2.26e-05	2	166	2	11448776
Pubmed	Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptor.	LDLR PCSK9	2.26e-05	2	166	2	18753623
Pubmed	EED-mediated histone methylation is critical for CNS myelination and remyelination by inhibiting WNT, BMP, and senescence pathways.	EED EZH2	2.26e-05	2	166	2	32851157
Pubmed	Mitotically stable association of polycomb group proteins eed and enx1 with the inactive x chromosome in trophoblast stem cells.	EED EZH2	2.26e-05	2	166	2	12123576
Pubmed	PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells.	LDLR PCSK9	2.26e-05	2	166	2	25110901
Pubmed	Characterization of LDLR rs5925 and PCSK9 rs505151 genetic variants frequencies in healthy subjects from northern Chile: Influence on plasma lipid levels.	LDLR PCSK9	2.26e-05	2	166	2	31441123
Pubmed	Structural basis of EZH2 recognition by EED.	EED EZH2	2.26e-05	2	166	2	17937919
Pubmed	Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling.	LDLR PCSK9	2.26e-05	2	166	2	33606190
Pubmed	Effect of a splice site mutation in LDLR gene and two variations in PCSK9 gene in Tunisian families with familial hypercholesterolaemia.	LDLR PCSK9	2.26e-05	2	166	2	21115573
Pubmed	Molecular and functional mapping of EED motifs required for PRC2-dependent histone methylation.	EED EZH2	2.26e-05	2	166	2	17997413
Pubmed	Loss- and gain-of-function PCSK9 variants: cleavage specificity, dominant negative effects, and low density lipoprotein receptor (LDLR) degradation.	LDLR PCSK9	2.26e-05	2	166	2	22875854
Pubmed	LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers.	LDLR PCSK9	2.26e-05	2	166	2	26820623
Pubmed	Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation.	LDLR PCSK9	2.26e-05	2	166	2	17452316
Pubmed	Characterization of interactions between the mammalian polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian polycomb-group protein complexes.	EED EZH2	2.26e-05	2	166	2	9584199
Pubmed	PCSK9-mediated degradation of the LDL receptor generates a 17 kDa C-terminal LDL receptor fragment.	LDLR PCSK9	2.26e-05	2	166	2	23509406
Pubmed	Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients.	LDLR PCSK9	2.26e-05	2	166	2	31491741
Pubmed	Blood lipid-related low-frequency variants in LDLR and PCSK9 are associated with onset age and risk of myocardial infarction in Japanese.	LDLR PCSK9	2.26e-05	2	166	2	29802317
Pubmed	Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Single Domain Antibodies Are Potent Inhibitors of Low Density Lipoprotein Receptor Degradation.	LDLR PCSK9	2.26e-05	2	166	2	27284008
Pubmed	Loss of maternal EED results in postnatal overgrowth.	EED EZH2	2.26e-05	2	166	2	30005706
Pubmed	Role of ubiquitination in PCSK9-mediated low-density lipoprotein receptor degradation.	LDLR PCSK9	2.26e-05	2	166	2	22074827
Pubmed	A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates.	LDLR PCSK9	2.26e-05	2	166	2	19443683
Pubmed	Targeted ablation of NrCAM or ankyrin-B results in disorganized lens fibers leading to cataract formation.	ANK2 NRCAM	2.26e-05	2	166	2	11449000
Pubmed	Low density lipoprotein binds to proprotein convertase subtilisin/kexin type-9 (PCSK9) in human plasma and inhibits PCSK9-mediated low density lipoprotein receptor degradation.	LDLR PCSK9	2.26e-05	2	166	2	23400816
Pubmed	Heparan sulfate proteoglycans present PCSK9 to the LDL receptor.	LDLR PCSK9	2.26e-05	2	166	2	28894089
Pubmed	Identification of amino acid residues in the ligand binding repeats of LDL receptor important for PCSK9 binding.	LDLR PCSK9	2.26e-05	2	166	2	30617148
Pubmed	The EphA4 receptor regulates neuronal morphology through SPAR-mediated inactivation of Rap GTPases.	SIPA1L1 EPHA4	2.26e-05	2	166	2	18094260
Pubmed	Molecular basis for LDL receptor recognition by PCSK9.	LDLR PCSK9	2.26e-05	2	166	2	18250299
Pubmed	Non-hematopoietic deficiency of proprotein convertase subtilisin/kexin type 9 deficiency leads to more severe anemia in a murine model of sickle cell disease.	LDLR PCSK9	2.26e-05	2	166	2	33020528
Pubmed	EZH2 Loss Drives Resistance to Carboplatin and Paclitaxel in Serous Ovarian Cancers Expressing ATM.	EZH2 ATM	2.26e-05	2	166	2	31704732
Pubmed	Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization study.	LDLR PCSK9	2.26e-05	2	166	2	33886544
Pubmed	β-Estradiol results in a proprotein convertase subtilisin/kexin type 9-dependent increase in low-density lipoprotein receptor levels in human hepatic HuH7 cells.	LDLR PCSK9	2.26e-05	2	166	2	25913303
Pubmed	PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia.	EED EZH2	2.26e-05	2	166	2	30404791
Pubmed	Genetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with Berberine.	LDLR PCSK9	2.26e-05	2	166	2	27015087
Pubmed	Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9.	LDLR PCSK9	2.26e-05	2	166	2	28750079
Pubmed	The M2 module of the Cys-His-rich domain (CHRD) of PCSK9 protein is needed for the extracellular low-density lipoprotein receptor (LDLR) degradation pathway.	LDLR PCSK9	2.26e-05	2	166	2	23105118
Pubmed	Patterns and tempo of PCSK9 pseudogenizations suggest an ancient divergence in mammalian cholesterol homeostasis mechanisms.	LDLR PCSK9	2.26e-05	2	166	2	33515402
Pubmed	PCSK9-D374Y Suppresses Hepatocyte Migration through Downregulating Free Cholesterol Efflux Rate and Activity of Extracellular Signal-Regulated Kinase.	LDLR PCSK9	2.26e-05	2	166	2	36655117
Pubmed	Screening of PCSK9 and LDLR genetic variants in Familial Hypercholesterolemia (FH) patients in India.	LDLR PCSK9	2.26e-05	2	166	2	33864011
Pubmed	Autophagy maintains stemness by preventing senescence.	ATG7 PAX7	2.26e-05	2	166	2	26738589
Pubmed	In Silico Insights into Protein-protein Interaction Disruptive Mutations in the PCSK9-LDLR complex.	LDLR PCSK9	2.26e-05	2	166	2	32106405
Pubmed	Mechanistic implications for LDL receptor degradation from the PCSK9/LDLR structure at neutral pH.	LDLR PCSK9	2.26e-05	2	166	2	22081141
Pubmed	Opposing roles of polycomb repressive complexes in hematopoietic stem and progenitor cells.	EED EZH2	2.26e-05	2	166	2	20445021
Pubmed	Deletion of Polycomb Repressive Complex 2 From Mouse Intestine Causes Loss of Stem Cells.	EED EZH2	2.26e-05	2	166	2	27342214
Pubmed	Low-density lipoprotein (LDL)-dependent uptake of Gram-positive lipoteichoic acid and Gram-negative lipopolysaccharide occurs through LDL receptor.	LDLR PCSK9	2.26e-05	2	166	2	30002483
Pubmed	Several phenylalanine-glycine motives in the nucleoporin Nup214 are essential for binding of the nuclear export receptor CRM1.	NUP214 XPO1	2.26e-05	2	166	2	23264634
Pubmed	Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia.	LDLR PCSK9	2.26e-05	2	166	2	27206942
Pubmed	A Therapeutic Peptide Vaccine Against PCSK9.	LDLR PCSK9	2.26e-05	2	166	2	28970592
Pubmed	Nup214 is required for CRM1-dependent nuclear protein export in vivo.	NUP214 XPO1	2.26e-05	2	166	2	16943420
Pubmed	PCSK9 deficiency results in a specific shedding of excess LDLR in female mice only: Role of hepatic cholesterol.	LDLR PCSK9	2.26e-05	2	166	2	35985474
Pubmed	Ubiquitin-specific protease 34 in macrophages limits CD8 T cell-mediated onset of vitiligo in mice.	USP34 ATM	2.26e-05	2	166	2	37043976
Pubmed	A proprotein convertase subtilisin-like/kexin type 9 (PCSK9) C-terminal domain antibody antigen-binding fragment inhibits PCSK9 internalization and restores low density lipoprotein uptake.	LDLR PCSK9	2.26e-05	2	166	2	20172854
Pubmed	Antisense inhibition of proprotein convertase subtilisin/kexin type 9 reduces serum LDL in hyperlipidemic mice.	LDLR PCSK9	2.26e-05	2	166	2	17242417
Pubmed	Characterization of the repressor function of the nuclear orphan receptor retinoid receptor-related testis-associated receptor/germ cell nuclear factor.	NR6A1 NCOR1	2.26e-05	2	166	2	10940306
Pubmed	Ezh2 maintains a key phase of muscle satellite cell expansion but does not regulate terminal differentiation.	EZH2 PAX7	2.26e-05	2	166	2	23203812
Pubmed	Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia.	LDLR PCSK9	2.26e-05	2	166	2	16183066
Interaction	RCOR1 interactions	USP34 NOL4 NR2C1 MYCBP2 BEND3 ICE1 EZH2 ANKHD1 BIRC6 KIF20B NCOR1 RESF1 TET1 DOCK7 TMF1 ANKRD17 PAX7 TASOR OBI1	1.49e-08	494	160	19	int:RCOR1
Interaction	PFN1 interactions	RAD52 EED ANK2 MAP1A ATG7 NUMBL EZH2 ANKHD1 BIRC6 CTTNBP2NL PDLIM5 GRID2IP AKAP9 KIAA1217 DOCK7 TMF1 MACF1 AKAP13	1.29e-07	509	160	18	int:PFN1
Interaction	KDM1A interactions	USP34 NOL4 NR2C1 EED MYCBP2 BEND3 ICE1 NUP214 XPO1 EZH2 ANKHD1 BIRC6 KIF20B NCOR1 RESF1 AKAP9 SUPT5H KIAA1217 TET1 DOCK7 TMF1 ANKRD17 TASOR OBI1	4.19e-07	941	160	24	int:KDM1A
Interaction	PHF21A interactions	USP34 NOL4 MYCBP2 BEND3 ICE1 NUP214 ANKHD1 BIRC6 KIF20B RESF1 TET1 DOCK7 TMF1 OBI1	6.45e-07	343	160	14	int:PHF21A
Interaction	DYRK1A interactions	MYT1L USP34 DCHS2 RAD18 MYCBP2 KIAA0232 ICE1 NUP214 XPO1 ANKHD1 CTTNBP2NL DCAF5 PDLIM5 PPP4R2 KIAA1217 SIPA1L1 DOCK7	1.98e-06	552	160	17	int:DYRK1A
Interaction	YWHAH interactions	USP53 KIF21B NEDD4L NUMBL MYCBP2 KIAA0232 CHMP5 HECTD4 XPO1 CDCA2 KANK1 GRID2IP RESF1 AKAP9 KIAA1217 SIPA1L1 TET1 KCNK3 DOCK7 ANKRD17 MACF1 AKAP13 PDCL PPIP5K2 EDRF1	2.00e-06	1102	160	25	int:YWHAH
Interaction	TNIK interactions	NEDD4L ANK2 MYCBP2 SYNE1 BEND3 XPO1 CTTNBP2NL STRN AKAP9 KIAA1217 SIPA1L1 DOCK7 MACF1 RIMBP2	2.23e-06	381	160	14	int:TNIK
Interaction	TULP3 interactions	RAD18 WAPL NUMBL BEND3 ANKHD1 BIRC6 DCAF5 PDLIM5 NCOR1 STRN AKAP9 PDCL ZNF292	4.09e-06	346	160	13	int:TULP3
Interaction	PRRG1 interactions	NEDD4L DCAF10 HECW2 UQCRH	4.88e-06	15	160	4	int:PRRG1
Interaction	NANOG interactions	RAD52 USP34 EED WAPL NOL6 EZH2 KIF20B WTAP NCOR1 RESF1 AKAP9 KIAA1217 TET1 PAXIP1 SCAF11	7.06e-06	481	160	15	int:NANOG
Interaction	ZSWIM9 interactions	NOL4 WAPL WTAP ZNF292	1.07e-05	18	160	4	int:ZSWIM9
Interaction	YWHAZ interactions	RAD52 EED NEDD4L NUMBL MYCBP2 KIAA0232 HECTD4 TACC2 XPO1 EZH2 THAP9 WTAP NCOR1 STRN KANK1 AKAP9 ASXL3 SIPA1L1 KCNK3 DOCK7 ANKRD17 MACF1 AKAP13 SCAF11 ATM PPIP5K2	1.52e-05	1319	160	26	int:YWHAZ
Interaction	TERF2IP interactions	NR2C1 RAD18 EED WAPL BEND3 XPO1 EZH2 KIF20B WTAP CDCA2 NCOR1 SUPT5H SCAF11 TASOR ZNF292	3.53e-05	552	160	15	int:TERF2IP
Interaction	SYNGAP1 interactions	USP53 ANK2 MAP1A MYCBP2 DLGAP4 BIRC6 PDLIM5 STRN SIPA1L1 PPA2 AKAP13	3.56e-05	307	160	11	int:SYNGAP1
Interaction	CT45A5 interactions	RAD18 ANKHD1 KANK1 SUPT5H PPP4R2 ANKRD17	3.65e-05	78	160	6	int:CT45A5
Interaction	USP21 interactions	EED SYNE1 BEND3 XPO1 USP20 TGFBR2 HECW2 SIPA1L1	4.45e-05	161	160	8	int:USP21
Interaction	YWHAG interactions	USP53 KIF21B EED NEDD4L NUMBL MYCBP2 KIAA0232 HECTD4 XPO1 EZH2 CDCA2 KANK1 GRID2IP AKAP9 SIPA1L1 TET1 KCNK3 DOCK7 ANKRD17 MACF1 AKAP13 SCAF11 PPIP5K2 EDRF1	4.99e-05	1248	160	24	int:YWHAG
Interaction	HERC2 interactions	EED ANK2 MYCBP2 ARRDC5 HECTD4 XPO1 CPT1A BIRC6 USP20 RMI1 AKAP9 DOCK7 MACF1 HPS5	5.02e-05	503	160	14	int:HERC2
Interaction	ARL16 interactions	NOL6 BEND3 BIRC6 CDCA2 NCOR1 TASOR	5.20e-05	83	160	6	int:ARL16
Interaction	BNIP5 interactions	USP34 ANKHD1 PDLIM5 ANKRD17	8.93e-05	30	160	4	int:BNIP5
Interaction	TUBGCP3 interactions	EED XPO1 TUBGCP5 AKAP12 AKAP9 HECW2 DOCK7 SCAF11 UQCRH	9.21e-05	229	160	9	int:TUBGCP3
Interaction	PIP interactions	USP53 NOL4 KIAA0232 CTTNBP2NL USP20 RMI1 KANK1 SIPA1L1	1.01e-04	181	160	8	int:PIP
Interaction	ARPC3 interactions	EED ATG7 MYCBP2 MYO19 XPO1 EZH2 ASXL3 DOCK7	1.09e-04	183	160	8	int:ARPC3
Interaction	ARPC2 interactions	EED ATG7 MYCBP2 MYO19 XPO1 EZH2 PDLIM5 ASXL3	1.27e-04	187	160	8	int:ARPC2
Interaction	MAP1LC3A interactions	NEDD4L ANK2 MAP1A ATG7 BIRC6 TBC1D16 NCOR1 RESF1 AKAP13	1.36e-04	241	160	9	int:MAP1LC3A
Cytoband	7p14	TRGV2 TRGV3 TRGV4	1.75e-04	30	166	3	7p14
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	AKAP3 AKAP12 AKAP9 AKAP13	2.55e-05	29	108	4	396
GeneFamily	T cell receptor gamma locus at 7p14	TRGV2 TRGV3 TRGV4	2.94e-04	22	108	3	375
GeneFamily	Lysine methyltransferases\|Myb/SANT domain containing\|Polycomb repressive complex 2	EED EZH2	5.22e-04	6	108	2	1347
GeneFamily	WD repeat domain containing	KIF21B EED DCAF5 STRN PLAA DCAF10 WDR89	9.96e-04	262	108	7	362
GeneFamily	Pleckstrin homology domain containing\|SH2 domain containing\|C2 and RasGAP domain containing	RASA4 RASA4B	1.54e-03	10	108	2	830
GeneFamily	Kinesins\|Pleckstrin homology domain containing	KIF21B KIF20B KIF4B	2.61e-03	46	108	3	622
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	LRIT2 NRCAM OBSCN HMCN1 SDK1	2.81e-03	161	108	5	593
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	RAD51C USP34 TUT4 WAPL MYCBP2 DUSP4 XPO1 LARP4 LDLR KIF20B ADCY9 PDLIM5 PIKFYVE TGFBR2 AKAP9 SIPA1L1 ANKRD17 MACF1 AKAP13 PRMT3 PPIP5K2 TASOR EPHA4 ZNF292	9.29e-10	856	165	24	M4500
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	KIF21B USP34 TUT4 WAPL MYCBP2 SYNE1 DUSP4 HECTD4 ICE1 XPO1 BIRC6 INO80D DCAF5 USP20 LAX1 PIKFYVE TGFBR2 NCOR1 RESF1 AKAP9 JCHAIN TMF1 MACF1 PCNX1 AKAP13 SCAF11 ATM TASOR ZNF292	5.55e-08	1492	165	29	M40023
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	TUT4 WAPL KIAA0232 ICE1 XPO1 ADCY9 PIKFYVE STRN KANK1 AKAP9 SCAF11 PPIP5K2 EDRF1	6.27e-08	300	165	13	M8702
Coexpression	GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN	NR2C1 TUT4 SYNE1 HECTD4 CES2 CRYL1 MACF1 AKAP13 SCAF11 TASOR	5.71e-07	199	165	10	M7607
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	RAD18 TUT4 MYCBP2 XPO1 ANKHD1 KIF20B RMI1 RESF1 PPP4R2 TMF1 SCAF11 ATM PPIP5K2 TASOR OBI1 ZNF654	4.27e-06	656	165	16	M18979
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	USP53 RAD18 NEDD4L NRCAM MAP1A SYNE1 DLGAP4 HECTD4 CPT1A ANKHD1 CHML ADCY9 USP20 TBC1D16 CDCA2 NCOR1 STRN KANK1 DOCK7 PCNX1 LTBP1	6.27e-06	1102	165	21	M2369
Coexpression	ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP	USP53 NR2C1 CAAP1 EED CHMP5 ICE1 CHML PPP4R2 JCHAIN PPA2 TMF1 ATM UQCRH PPIP5K2 TASOR EDRF1	7.62e-06	687	165	16	M41022
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	USP53 RAD18 NEDD4L NRCAM MAP1A SYNE1 DLGAP4 HECTD4 CPT1A ANKHD1 CHML ADCY9 USP20 TBC1D16 CDCA2 NCOR1 STRN KANK1 DOCK7 PCNX1 LTBP1	8.47e-06	1124	165	21	MM1070
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	TUT4 WAPL MYCBP2 XPO1 LARP4 KIF20B PIKFYVE AKAP9 ANKRD17 PRMT3 TASOR EPHA4 ZNF292	8.61e-06	466	165	13	M13522
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	KIF21B TUT4 BIRC6 NCOR1 SIPA1L1 MACF1 PWWP3B ATM	1.94e-05	180	165	8	M8239
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NE_PRECURSOR_CELL	NOL4 NAAA ANK2 NRCAM TACC2 USP20 KCNT2 RASA4 RASA4B RIMBP2	2.44e-05	304	165	10	M45711
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HSERT	NOL4 ANK2 MYCBP2 THSD7B SLITRK1 ANO8 RASA4 ASXL3 SCN7A KCNK3 RIMBP2 TAFA5	3.00e-05	450	165	12	M39072
Coexpression	DAZARD_UV_RESPONSE_CLUSTER_G6	TUT4 WAPL XPO1 ADCY9 PIKFYVE STRN EDRF1	3.84e-05	145	165	7	M1810
Coexpression	XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_200A_3P_GENES	BEND3 SIPA1L1 RIMBP2	3.89e-05	11	165	3	MM17498
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBGABA	MYT1L KIF21B NOL4 ANK2 MYCBP2 THSD7B SLITRK1 ANO8 AKAP9 RASA4 ASXL3 SCN7A RIMBP2 TAFA5 ZNF292	4.07e-05	703	165	15	M39070
Coexpression	GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN	CR2 LAX1 AKAP12 CDCA2 JCHAIN TMF1 TASOR ZNF292	4.12e-05	200	165	8	M8088
Coexpression	PUJANA_ATM_PCC_NETWORK	RAD51C KIF21B USP34 CMKLR2 NR2C1 DRD1 EED OBSCN ICE1 NUP214 XPO1 CPT1A EZH2 KIF20B WTAP FBXL4 STRN PAXIP1 SCAF11 PRMT3 ATM PPIP5K2	6.67e-05	1394	165	22	M9585
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL	NOL4 NAAA ANK2 NRCAM NUMBL DUSP4 RASA4 RASA4B RIMBP2 SDK1 EPHA4	9.17e-05	429	165	11	M45694
Coexpression	SHEN_SMARCA2_TARGETS_UP	EED CHMP5 XPO1 ANKHD1 NCOR1 KANK1 ANKRD17 MACF1 TRAK2 UTP14C REV1	9.17e-05	429	165	11	M29
Coexpression	GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN	USP53 NEDD4L MYCBP2 CRYL1 TET1 PRMT3 ATM	9.75e-05	168	165	7	M7007
Coexpression	BENPORATH_OCT4_TARGETS	RAD51C CPT1A ANKHD1 ANO8 KANK1 RESF1 PLAA PDCL OBI1	9.75e-05	290	165	9	M17183
Coexpression	LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP	RAD18 NRCAM MYO19 FANCM EZH2 NCAPG2 ZFAND4 KIF20B ANO8 CDCA2 PAXIP1 KIF4B PPIP5K2 REV1	1.08e-04	680	165	14	MM456
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	PDLIM5 AKAP12 KANK1 KIAA1217 SIPA1L1 AKAP13 SDK1	1.30e-04	176	165	7	M39223
Coexpression	SCHLOSSER_SERUM_RESPONSE_DN	RAD52 EED MYCBP2 MINPP1 LDLR WTAP AKAP12 PIKFYVE JCHAIN DLEC1 BCAM PPIP5K2 HPS5 TASOR	1.57e-04	705	165	14	M1410
Coexpression	MURARO_PANCREAS_DUCTAL_CELL	NEDD4L DUSP4 CPT1A CHML LDLR CTTNBP2NL PDLIM5 TBC1D16 TGFBR2 RESF1 KIAA1217 SIPA1L1 MACF1 AKAP13 SCAF11 PWWP3B TRAK2 UQCRH IGSF3 ZNF292	1.61e-04	1276	165	20	M39173
Coexpression	GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP	KIF21B MYCBP2 SYNE1 CHMP5 MACF1 ATM HPS5	1.71e-04	184	165	7	M9005
Coexpression	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN	USP34 INO80D PDLIM5 CES2 TGFBR2 NCOR1 CRYL1 KANK1 AKAP9 RASA4 KIAA1217 TMF1 BCAM EPHA4 REV1	1.87e-04	807	165	15	M16651
Coexpression	PGF_UP.V1_UP	NRCAM LARP4 CR2 AKAP9 SCAF11 LTBP1 TASOR	2.09e-04	190	165	7	M2674
Coexpression	LAKE_ADULT_KIDNEY_C28_INTERSTITIUM	USP53 SYNE1 PDLIM5 AKAP12 KIAA1217	2.15e-04	86	165	5	M39247
Coexpression	LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES	SYNE1 AKAP12 TGFBR2 HECW2 KIAA1217 MACF1	2.37e-04	137	165	6	M39241
Coexpression	GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN	EZH2 ANKHD1 THAP9 WTAP SIPA1L1 HPS5 ZNF292	2.60e-04	197	165	7	M5342
Coexpression	GSE3982_EOSINOPHIL_VS_TH2_DN	NR2C1 XPO1 MINPP1 KIF20B PDLIM5 TBC1D16 OBI1	2.68e-04	198	165	7	M5425
Coexpression	GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN	CPT1A EZH2 CR2 USP20 ADGRE3 PDCL ZNF654	2.68e-04	198	165	7	M5776
Coexpression	GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_UP	KIF21B WAPL SYNE1 CR2 TGFBR2 SIPA1L1 EPHA4	2.77e-04	199	165	7	M9414
Coexpression	GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP	USP34 NR2C1 TUT4 MYCBP2 CES2 MACF1 AKAP13	2.77e-04	199	165	7	M7596
Coexpression	GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN	KIF21B TUT4 PGAP6 INO80D AKAP13 HPS5 ZNF292	2.85e-04	200	165	7	M9463
Coexpression	GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_UP	CAAP1 MYCBP2 BIRC6 NCAPG2 AKAP12 AKAP9 RASA4	2.85e-04	200	165	7	M4021
Coexpression	GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP	USP34 CYSLTR1 RAB42 CTTNBP2NL ZFAND4 ADCY9 RASA4	2.85e-04	200	165	7	M6611
Coexpression	GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_UP	NCAPG2 ZFAND4 ADCY9 FBXL4 PIKFYVE CRYL1 RASA4	2.85e-04	200	165	7	M6623
Coexpression	GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_UP	USP53 MYCBP2 BIRC6 WTAP STRN ANKRD17 ZNF292	2.85e-04	200	165	7	M9041
Coexpression	GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN	BIRC6 GRID2IP TET1 SCN7A MACF1 LMNTD1	3.09e-04	144	165	6	M335
Coexpression	HALLMARK_UV_RESPONSE_DN	SYNE1 LDLR PDLIM5 TGFBR2 SIPA1L1 LTBP1	3.09e-04	144	165	6	M5942
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL	NOL4 NAAA ANK2 DUSP4 TACC2 RASA4 RASA4B RIMBP2	3.10e-04	268	165	8	M45696
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	CAAP1 RAD18 TUT4 EED WAPL NEDD4L ANK2 NRCAM TRAF3IP1 BEND3 XPO1 FANCM EZH2 CHML KIF20B CDCA2 AKAP9 KCNT2 TET1 PAXIP1 DOCK7 MACF1 SCAF11 PWWP3B ATM TAFA5 PDCL OBI1 ZNF292	4.66e-08	1257	158	29	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000	USP53 CAAP1 RAD18 NAAA NR6A1 THSD7B LARP4 BIRC6 SLITRK1 PLAA PDCL PPIP5K2	1.85e-07	233	158	12	gudmap_developingGonad_e12.5_ovary_k5_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	NOL4 CAAP1 RAD18 TUT4 EED WAPL NEDD4L ANK2 NRCAM TRAF3IP1 BEND3 XPO1 FANCM EZH2 CHML KIF20B CDCA2 AKAP9 KCNT2 TET1 PAXIP1 DOCK7 MACF1 SCAF11 PWWP3B ATM TAFA5 PDCL OBI1 ZNF292	3.23e-07	1459	158	30	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	EED WAPL MYO19 FANCM LARP4 BIRC6 KIF20B CDCA2 KANK1 PLAA KCNT2 PPP4R2 PAXIP1 TMF1 SCAF11 ATM UTP14C	4.94e-07	532	158	17	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000	NR2C1 CAAP1 DRD1 ICE1 CDCA2 NCOR1 PLAA HMCN1 HECW2 LTBP1 PAX7 PDCL IGSF3 EPHA4 ZNF292	4.27e-06	492	158	15	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000	USP53 CAAP1 RAD18 NAAA NR6A1 THSD7B LARP4 BIRC6 SLITRK1 CDCA2 RESF1 PLAA ASXL3 KIAA1217 TET1 ANKRD17 SCAF11 PDCL PPIP5K2	8.83e-06	804	158	19	gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_1000	USP53 RAD18 NAAA THSD7B ANKHD1 LARP4 BIRC6 PDCL	9.21e-06	138	158	8	gudmap_developingGonad_e12.5_epididymis_k5_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500	TUT4 WAPL TRAF3IP1 ATG7 EZH2 CTTNBP2NL SLITRK1 KIF20B AKAP9 ASXL3 TMF1 MACF1 PWWP3B PPIP5K2	1.95e-05	492	158	14	Facebase_RNAseq_e10.5_Mandibular Arch_500
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000	USP53 USP34 RAD18 NAAA NR6A1 THSD7B ANKHD1 LARP4 BIRC6 PDLIM5 STRN RESF1 PLAA HMCN1 ANKRD17 ATM PDCL PPIP5K2	1.98e-05	776	158	18	gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2	NR2C1 TRAF3IP1 MYCBP2 DLGAP4 ICE1 XPO1 FANCM EZH2 LARP4 WTAP PPP4R2 ANKRD17 MACF1 TASOR ZNF292	2.15e-05	564	158	15	Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#3_top-relative-expression-ranked_1000	ANK2 NUP214 CTTNBP2NL ZFAND4 KIF20B CDCA2 EDRF1 ZNF292	2.35e-05	157	158	8	gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000_k3
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	KIF21B NOL4 RAD18 TUT4 NEDD4L ANK2 MAP1A NUMBL DLGAP4 FANCM EZH2 CHML PGAP6 KIF20B WTAP TBC1D16 CDCA2 RMI1 AKAP9 KCNT2 DOCK7 PWWP3B ATM OBI1 REV1	2.77e-05	1370	158	25	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#4_top-relative-expression-ranked_1000	THSD7B CTTNBP2NL ZFAND4 HECW2 ASXL3 PWWP3B IGSF3 EPHA4 ZNF292	3.32e-05	214	158	9	gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k4
CoexpressionAtlas	MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05	RAD52 NR2C1 TUT4 DIS3L2 ANK2 NRCAM OBSCN CHML MTERF4 AKAP12 ANO8 STRN GTF2IRD2B RASA4 KIAA1217 GTF2IRD2 RASA4B LOXL3 ATM SDK1 ZNF654 EPHA4 ZNF292	4.99e-05	1245	158	23	PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_500	USP53 NAAA THSD7B LARP4 BIRC6 SLITRK1	6.11e-05	91	158	6	gudmap_developingGonad_e12.5_ovary_k5_500
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000	USP53 RAD18 NAAA THSD7B ANKHD1 LARP4 BIRC6 CDCA2 RESF1 PLAA ASXL3 KIAA1217 TET1 ANKRD17 SCAF11 PDCL IGSF3	1.10e-04	806	158	17	gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000	USP34 RAD18 CYSLTR1 XPO1 ZFAND4 KIF20B PDLIM5 AKAP12 CDCA2 NCOR1 HMCN1 ASXL3 KIAA1217 TET1 SCN7A KCNS3 SCAF11	1.33e-04	819	158	17	gudmap_developingKidney_e15.5_Peripheral blastema_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000	NR2C1 CAAP1 DRD1 ICE1 THSD7B CTTNBP2NL CDCA2 NCOR1 PLAA HMCN1 HECW2 LTBP1 PAX7 PDCL IGSF3 EPHA4 ZNF292	1.70e-04	836	158	17	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3	WAPL TRAF3IP1 CPT1A EZH2 SLITRK1 CDCA2 AKAP9 TMF1 MACF1	2.02e-04	271	158	9	Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_1000	THSD7B ASXL3 SIPA1L1 LTBP1 IGSF3 EPHA4	2.80e-04	120	158	6	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#1_top-relative-expression-ranked_1000	USP34 THSD7B NCAPG2 CDCA2 NCOR1 HECW2 PDCL IGSF3 EPHA4 ZNF292	2.95e-04	349	158	10	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k1_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000	TUT4 WAPL TRAF3IP1 ATG7 THSD7B CPT1A EZH2 CTTNBP2NL SLITRK1 KIF20B CDCA2 AKAP9 RASA4 ASXL3 TMF1 MACF1 PWWP3B PPIP5K2	3.66e-04	978	158	18	Facebase_RNAseq_e10.5_Mandibular Arch_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	RAD18 TUT4 WAPL NAAA NEDD4L XPO1 FANCM EZH2 CTTNBP2NL KIF20B CDCA2 RESF1 AKAP9 TET1 DOCK7 PWWP3B ATM PPIP5K2 ZNF654 EPHA4 ZNF292	4.06e-04	1252	158	21	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000	NRCAM DUSP4 NOL6 BEND3 NR6A1 FANCM SLITRK1 KIF20B PDLIM5 KANK1 KCNT2 PPP4R2 WDR89 SCAF11 ATM PAX7 TAFA5 UTP14C	4.28e-04	991	158	18	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	WAPL TRAF3IP1 EZH2 KIF20B AKAP9 TMF1 MACF1	4.96e-04	186	158	7	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000	TUT4 MYCBP2 NUP214 BIRC6 PDLIM5 KANK1 AKAP9 KIAA1217 ZNF654 ZNF292	5.18e-04	375	158	10	gudmap_developingKidney_e15.5_cortic collect duct_1000_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500	CAAP1 NCOR1 PLAA HECW2 LTBP1 IGSF3 EPHA4 ZNF292	5.38e-04	247	158	8	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k4
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000	TUT4 MYCBP2 NUP214 BIRC6 NCOR1 KANK1 AKAP9 KIAA1217 AKAP13 EPHA4	5.62e-04	379	158	10	gudmap_developingKidney_e15.5_1000_k3
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP34 MYCBP2 XPO1 BIRC6 RESF1 AKAP9 MACF1 AKAP13 SCAF11 ATM ZNF292	2.63e-10	200	166	11	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NOL4 NRCAM OBSCN HMCN1 GUCY2F OTOGL ASXL3 SDK1	4.67e-07	184	166	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUT4 MYCBP2 BIRC6 AKAP12 NCOR1 MACF1 SCAF11 TASOR	4.67e-07	184	166	8	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NOL4 NRCAM OBSCN HMCN1 GUCY2F OTOGL ASXL3 SDK1	4.67e-07	184	166	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NOL4 NRCAM OBSCN HMCN1 GUCY2F OTOGL ASXL3 SDK1	4.67e-07	184	166	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	MYCBP2 XPO1 BIRC6 LDLR TGFBR2 MACF1 EDRF1 ZNF292	6.19e-07	191	166	8	9454f642c3621370fa23640b631301346b300950
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP34 ATG7 ANKHD1 BIRC6 SIPA1L1 ANKRD17 PCNX1 AKAP13	6.70e-07	193	166	8	779276e775cb2492e8dd36436295a536084a6415
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	USP34 CHML BIRC6 STRN AKAP9 DCAF10 PCNX1 SCAF11	6.70e-07	193	166	8	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	NEDD4L ANK2 OBSCN TACC2 PDLIM5 OTOGL LTBP1 EPHA4	6.97e-07	194	166	8	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP34 SYNE1 TUBGCP5 AKAP12 AKAP9 MACF1 ATM ZNF292	7.82e-07	197	166	8	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ANK2 NRCAM SYNE1 AKAP12 AKAP9 MACF1 LTBP1 SDK1	8.76e-07	200	166	8	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	DRD1 MAP1A SYNE1 TACC2 PDLIM5 KANK1 KCNT2 LTBP1	8.76e-07	200	166	8	9169a9ec8e9ab95d90a64c5a19ac666a5cf82313
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Cortical_neuron\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	MYT1L NOL4 NEDD4L ANK2 DLGAP4 AKAP9 RIMBP2 IGSF3	8.76e-07	200	166	8	5b3df61ff421846ef4cabf1bd5355534c8b95509
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	TUT4 SYNE1 LDLR AKAP9 MACF1 PCNX1 ATM	3.70e-06	171	166	7	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ANK2 MAP1A SYNE1 HECTD4 DCAF5 LOXL3 HPS5	4.31e-06	175	166	7	1d8aab491dcc27ea5dbfb6462d18ee280b21a05e
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ANK2 MAP1A SYNE1 HECTD4 DCAF5 LOXL3 HPS5	4.31e-06	175	166	7	427a7ee92fe16a90625946492062d37aa0f7235b
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DUSP4 RAB42 INO80D AKAP12 STRN HMCN1 DISP2	4.64e-06	177	166	7	8ef41ee5d63737b810ad7371b0437625e7e1badf
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____fenestrated_capillary_endothelial\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1A AKAP12 RASA4 HECW2 KCNK3 LTBP1 EPHA4	5.18e-06	180	166	7	79c5725f02e038d0187f4a1e1591f2492538aa57
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DUSP4 RAB42 CR2 STRN HMCN1 HECW2 DISP2	5.37e-06	181	166	7	4df7972f88117108698efd06b124b232f8588981
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DUSP4 RAB42 CR2 STRN HMCN1 HECW2 DISP2	5.37e-06	181	166	7	cbb530566893281289026bfd93adf721decd4ca3
ToppCell	URO-Lymphocyte-T_NK-T_NK_proliferative\|URO / Disease, Lineage and Cell Type	DUSP4 EZH2 NCAPG2 KIF20B CDCA2 KCNS3 KIF4B	6.20e-06	185	166	7	0ae9c646679c69a553eda670aef0e0495feb0286
ToppCell	Brain_organoid-organoid_Kanton_Nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	WAPL ICE1 EZH2 LDLR NCOR1 AKAP9 PPP4R2	6.20e-06	185	166	7	857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	MYCBP2 XPO1 BIRC6 LDLR RASA4 MACF1 ZNF292	6.20e-06	185	166	7	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	SYNE1 DUSP4 RESF1 AKAP9 MACF1 ATM	6.24e-06	121	166	6	19333a660800b583fa27b495c1f7828e6636a257
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	USP34 WAPL TRAF3IP1 BIRC6 RESF1 HMCN1 SCAF11	6.42e-06	186	166	7	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	NEDD4L ANK2 OBSCN TACC2 PDLIM5 LTBP1 EPHA4	6.89e-06	188	166	7	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	USP53 ANK2 AKAP12 HMCN1 SCN7A LTBP1 SDK1	7.38e-06	190	166	7	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP34 WAPL LARP4 NCOR1 TMF1 SCAF11 TASOR	7.64e-06	191	166	7	60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP34 WAPL LARP4 NCOR1 TMF1 SCAF11 TASOR	7.64e-06	191	166	7	09db184cb90fe282a14474d7217068c58092c6f8
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP34 WAPL LARP4 NCOR1 TMF1 SCAF11 TASOR	7.64e-06	191	166	7	973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP53 ANK2 HMCN1 SCN7A MACF1 LTBP1 SDK1	7.90e-06	192	166	7	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SYNE1 TUBGCP5 AKAP12 AKAP9 MACF1 ATM ZNF292	8.18e-06	193	166	7	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP34 WAPL AKAP12 AKAP9 TMF1 MACF1 SCAF11	8.46e-06	194	166	7	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NEDD4L SYNE1 TACC2 LDLR ADCY9 KANK1 TAFA5	8.46e-06	194	166	7	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 LDLR NCOR1 AKAP9 MACF1 SCAF11 PCSK9	8.74e-06	195	166	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	NEDD4L SYNE1 TACC2 KIAA1217 MACF1 SDK1 LMNTD1	9.04e-06	196	166	7	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	NEDD4L SYNE1 TACC2 KIAA1217 MACF1 SDK1 LMNTD1	9.04e-06	196	166	7	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP53 ANK2 HMCN1 SCN7A MACF1 LTBP1 SDK1	9.04e-06	196	166	7	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ANK2 NRCAM SYNE1 AKAP12 MACF1 LTBP1 TAFA5	9.35e-06	197	166	7	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	IPF-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	TRPM6 TACC2 RASA4 RASA4B AKAP13 BCAM EPHA4	9.66e-06	198	166	7	b8bd1ba268480f54451648e01631b615a3401144
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	MYCBP2 CHMP5 KIF20B AKAP9 TMF1 SCAF11 TRAK2	9.66e-06	198	166	7	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP53 ANK2 HMCN1 SCN7A MACF1 LTBP1 SDK1	9.66e-06	198	166	7	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NEDD4L TACC2 NR6A1 LDLR ADCY9 KANK1 KIAA1217	9.98e-06	199	166	7	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	ANK2 MYCBP2 WTAP AKAP12 TGFBR2 LTBP1 SDK1	9.98e-06	199	166	7	fde2b65afde69f402f1b7b056eaa266e9fd5b227
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	CHMP5 DUSP4 AKAP9 TMF1 SCAF11 HPS5 ZNF292	9.98e-06	199	166	7	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	USP34 TUT4 BIRC6 RESF1 HMCN1 KIAA1217 MACF1	1.03e-05	200	166	7	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK2 AKAP12 KCNT2 HMCN1 SCN7A LTBP1 SDK1	1.03e-05	200	166	7	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	MYT1L KIF21B MYCBP2 SLITRK1 AKAP9 ASXL3 SDK1	1.03e-05	200	166	7	bad32a95b759fad509401b07bc96a56687c2a592
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK2 SYNE1 AKAP12 KCNT2 HMCN1 SCN7A LTBP1	1.03e-05	200	166	7	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	MYT1L NOL4 NEDD4L DLGAP4 AKAP9 ASXL3 IGSF3	1.03e-05	200	166	7	306926cb7a847871641f02e03d52dc56fd55711c
ToppCell	Sigmoid-(1)_T_cell-(18)_cycling_gd_T\|Sigmoid / shred on region, Cell_type, and subtype	NUMBL NCAPG2 DCAF5 KIF20B AKAP12 RMI1 HECW2	1.03e-05	200	166	7	6e367abd1a4b87e20eb9095b8337723163e8bbae
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	USP53 ANK2 AKAP12 HMCN1 SCN7A LTBP1 SDK1	1.03e-05	200	166	7	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Sigmoid-T_cell-cycling_gd_T\|Sigmoid / Region, Cell class and subclass	NUMBL NCAPG2 DCAF5 KIF20B AKAP12 RMI1 HECW2	1.03e-05	200	166	7	9769185abae084ffac36420c749625e679b70ca8
ToppCell	ILEUM-non-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TUT4 TBC1D16 MACF1 AKAP13 HPS5 ZNF292	1.17e-05	135	166	6	b7a792a7c0c22d8b703509f134115f0e394d7de0
ToppCell	Severe-B_naive-1\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	TUT4 WAPL ICE1 CR2 MTERF4 MACF1	2.95e-05	159	166	6	2881b054bbeb479221ee3c38bbd9b0815b123579
ToppCell	IPF-Epithelial-PNEC\|Epithelial / Disease state, Lineage and Cell class	MYT1L NOL4 NRCAM ASXL3 KCNK3 RIMBP2	3.28e-05	162	166	6	865d0e215d54fb1412f00cf0649c71c2f1878e57
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF21B CR2 CRYL1 KANK1 DLEC1 LOXL3	3.51e-05	164	166	6	0853e75b60b2a78257b660910c3ee15b09c5f5b0
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EZH2 NCAPG2 KIF20B CDCA2 GUCY2F KIF4B	3.63e-05	165	166	6	eec2d327c94832d1390314c93ef6a2be4648478b
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYT1L DCHS2 HECTD4 OTOGL KCNK3 KCNS3	4.29e-05	170	166	6	5570c0e825bca77613bf0ebde620cf744fa1cb84
ToppCell	390C-Lymphocytic-ILC-ILC-2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	RAD52 DUSP4 TRGV2 LDLR PPA2 OBI1	4.58e-05	172	166	6	84d16cd7f618c94888920680bdc9e7130d73fd75
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAD18 ANK2 DUSP4 TBC1D16 KCNK3 LOXL3	4.73e-05	173	166	6	3059325901b1e5e12a1a91183f14267288b2f600
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAD18 ANK2 DUSP4 TBC1D16 KCNK3 LOXL3	4.73e-05	173	166	6	36c8338463ee4cc432f568728d55989360f9a68d
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DUSP4 MEI4 RASA4 WDR89 KCNS3 LTBP1	5.04e-05	175	166	6	9a96794df049d8228fea57c1584c160191d36b56
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l2\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KIAA0232 EZH2 NCAPG2 ZFAND4 PAXIP1 LOXL3	5.20e-05	176	166	6	1510cdfcfb46ce1196a1220c07fb5f3986c81b78
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TUT4 WAPL SYNE1 ICE1 MACF1 PCNX1	5.37e-05	177	166	6	d3e6c768b88b7906f3c7fdd00ba20842212c14b1
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TUT4 WAPL SYNE1 ICE1 MACF1 PCNX1	5.37e-05	177	166	6	f8f101c772c043636bedd6b2ec81409b1d2599bf
ToppCell	COVID-19_Mild-Lymphoid_T/NK-NK_activated\|COVID-19_Mild / Disease group, lineage and cell class	TUT4 WAPL SYNE1 ICE1 MACF1 PCNX1	5.37e-05	177	166	6	6978a22fef40c8b455342373abe7593f5ede0fa4
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	TUT4 WAPL SYNE1 ICE1 MACF1 PCNX1	5.37e-05	177	166	6	936ab2b180a052387124f68d0c7f41c0b164e748
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TUT4 WAPL SYNE1 ICE1 MACF1 PCNX1	5.37e-05	177	166	6	d5aeda113afaa2425874394610344570c9078478
ToppCell	ILEUM-inflamed-(9)_Enteric_neurons\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ANK2 OTOGL ASXL3 KIAA1217 SCN7A KCNS3	5.54e-05	178	166	6	d9142151819afb0dc22bfb32a9c9dba5f553067d
ToppCell	343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2\|343B / Donor, Lineage, Cell class and subclass (all cells)	TRAF3IP1 MYO19 DUSP4 INO80D LAX1 LMNTD1	5.54e-05	178	166	6	5289ac61637224ae70ffbc2d164d73116f10af40
ToppCell	ILEUM-inflamed-(9)_Neuro_cell\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ANK2 OTOGL ASXL3 KIAA1217 SCN7A KCNS3	5.54e-05	178	166	6	611504b0a9e6318b18fba83787b03f9245c82252
ToppCell	367C-Lymphocytic-ILC-ILC-2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ATG7 TRGV2 MINPP1 TUBGCP5 CES2 WDR89	5.71e-05	179	166	6	5aa8465e943b6b666c7f8b1937fcc3764bfe91f6
ToppCell	droplet-Liver-LIVER_HEP-30m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 TGFBR2 HECW2 WDR89 MACF1 EPHA4	5.89e-05	180	166	6	dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCell	droplet-Liver-LIVER_HEP\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 TGFBR2 HECW2 WDR89 MACF1 EPHA4	5.89e-05	180	166	6	423454e3390080ae03bb3cbb267255ebfe4df080
ToppCell	Pericytes-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	DCHS2 NRCAM FAM135B KCNT2 KCNK3 LTBP1	6.08e-05	181	166	6	35c470988a93381eefa300831aabb813fa1b90bd
ToppCell	droplet-Marrow-nan-3m-Hematologic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUT4 MYCBP2 NCOR1 TET1 MACF1 TASOR	6.26e-05	182	166	6	e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCell	droplet-Marrow-nan-3m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUT4 MYCBP2 NCOR1 TET1 MACF1 TASOR	6.26e-05	182	166	6	1710eab3037a87609d21838be2d2d29c3bc36651
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NRCAM TACC2 MTERF4 KCNT2 LTBP1 TAFA5	6.26e-05	182	166	6	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	NRCAM GPR143 TACC2 KANK1 KCNK3 LTBP1	6.46e-05	183	166	6	a1d4f25e13f5b9e92a9ca0a804a7bed5df8fb2fe
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	NEDD4L SYNE1 TACC2 LDLR KANK1 IGSF3	6.46e-05	183	166	6	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	COVID-19_Mild-NK_activated\|COVID-19_Mild / Disease condition and Cell class	TUT4 WAPL SYNE1 ICE1 MACF1 PCNX1	6.46e-05	183	166	6	22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	PDLIM5 AKAP12 KCNT2 MACF1 AKAP13 SDK1	6.65e-05	184	166	6	d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	ANK2 OBSCN TACC2 PDLIM5 AKAP13 LTBP1	6.65e-05	184	166	6	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	MYCBP2 XPO1 BIRC6 RASA4 MACF1 ZNF292	7.06e-05	186	166	6	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WAPL MYCBP2 ANKHD1 NCOR1 AKAP9 SCAF11	7.28e-05	187	166	6	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	USP53 PDLIM5 AKAP12 KCNT2 LTBP1 SDK1	7.28e-05	187	166	6	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	Control-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	TRPM6 CYSLTR1 LDLR RASA4 RASA4B EPHA4	7.28e-05	187	166	6	5429ae85942b8ec3895cceb63c663de3c24ca064
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	USP34 BIRC6 INO80D LDLR MACF1 PCNX1	7.49e-05	188	166	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	Fibroblast-E_(Early_Fibroblastic_progenitor)\|World / shred on cell class and cell subclass (v4)	RAD18 ARRDC5 EZH2 NCAPG2 KIF20B CDCA2	7.49e-05	188	166	6	be3db9768364568f44e32ae6b3bf99e49b0978bb
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	NEDD4L TACC2 NR6A1 LDLR KANK1 KIAA1217	7.49e-05	188	166	6	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	ANK2 OBSCN TACC2 PDLIM5 KANK1 AKAP13	7.72e-05	189	166	6	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	PDLIM5 KANK1 HMCN1 SCN7A KCNK3 KCNS3	7.72e-05	189	166	6	9c2492c38f27e4c699b40680652e4c64911cce52
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	NEDD4L NRCAM SYNE1 KANK1 KIAA1217 ANKRD17	7.72e-05	189	166	6	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	renal_cortex_nuclei-Adult_normal_reference\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	USP53 TACC2 FAM135B CRYL1 AKAP13 RIMBP2	7.72e-05	189	166	6	a48df46274d51e84ffb40264646de7346104efb9
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	ANK2 OBSCN TACC2 PDLIM5 KIAA1217 AKAP13	7.72e-05	189	166	6	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	ANK2 OBSCN TACC2 PDLIM5 KANK1 AKAP13	7.94e-05	190	166	6	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SYNE1 TRGV2 LAX1 RESF1 MACF1 ATM	7.94e-05	190	166	6	d153a0bdedcd6865e6ee19575234a78b5d859ff1
ToppCell	wk_20-22-Hematologic_Lymphocytic-T_&_ILC-NKT1\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	KIF21B TRGV2 TRGV3 TRGV4 LAX1 ATM	7.94e-05	190	166	6	326002d7f9de5e425cee76d9a0277f42d79058e2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 NRCAM ASXL3 DOCK7 RIMBP2 SDK1	7.94e-05	190	166	6	4836ea19308d2a96694f12ab0653b7ce7b101d2f
Computational	Genes upregulated in subsets of cells of a given type within various tumors	SYNE1 RESF1 AKAP9 MACF1 ATM ZNF292	3.69e-06	49	93	6	GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN
Computational	Neighborhood of ATF2	CMKLR2 NOL4 DRD1 NEDD4L AKAP3 TACC2 USP20 FBXL4 GUCY2F SCN7A PAXIP1 PAX7	2.56e-05	330	93	12	MORF_ATF2
Computational	Neighborhood of CAMK4	CMKLR2 NOL4 DRD1 NEDD4L AKAP3 TACC2 FBXL4 GUCY2F SCN7A PAXIP1 PAX7	3.89e-05	290	93	11	MORF_CAMK4
Computational	Neighborhood of MLLT10	CMKLR2 NOL4 DRD1 AKAP3 TACC2 USP20 FBXL4 GUCY2F SCN7A PAXIP1 PAX7	5.63e-05	302	93	11	MORF_MLLT10
Computational	Neighborhood of SUPT3H	CMKLR2 NOL4 DRD1 NEDD4L AKAP3 TACC2 FBXL4 GUCY2F SCN7A PAXIP1 PAX7	1.18e-04	328	93	11	MORF_SUPT3H
Computational	Neighborhood of RAD51L3	CMKLR2 NOL4 DRD1 NEDD4L AKAP3 TACC2 USP20 FBXL4 GUCY2F SCN7A PAXIP1 PAX7	1.19e-04	387	93	12	MORF_RAD51L3
Drug	Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A	DRD1 EED DUSP4 LDLR AKAP9 ZNF654 EDRF1 EPHA4 ZNF292	3.05e-06	165	163	9	3851_UP
Drug	Dexamethasone acetate [1177-87-3]; Down 200; 9.2uM; PC3; HT_HG-U133A	RAD52 NEDD4L SYNE1 KIAA0232 MTERF4 INO80D PDLIM5 LAX1 EDRF1	1.19e-05	195	163	9	5797_DN
Drug	Ampicillin trihydrate [7177-48-2]; Up 200; 10uM; MCF7; HT_HG-U133A	CMKLR2 DLGAP4 GPR143 PDLIM5 NCOR1 AKAP9 PCNX1 ATM EDRF1	1.29e-05	197	163	9	1530_UP
Drug	Lobeline alpha (-) hydrochoride [134-63-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A	USP34 CMKLR2 NR2C1 NAAA LDLR NCOR1 STRN AKAP9 PCNX1	1.29e-05	197	163	9	6258_UP
Drug	Todralazine hydrochloride [3778-76-5]; Up 200; 14.8uM; PC3; HT_HG-U133A	RAD52 NRCAM CYSLTR1 SYNE1 NUP214 NR6A1 PDLIM5 STRN BCAM	1.34e-05	198	163	9	5087_UP
Disease	Malignant neoplasm of breast	RAD51C ANK2 NRCAM SYNE1 OBSCN TACC2 NUP214 CPT1A EZH2 AKAP12 NCOR1 AKAP9 KCNT2 GUCY2F OTOGL SIPA1L1 MACF1 DLEC1 ATM	5.71e-06	1074	159	19	C0006142
Disease	cholesteryl esters to total lipids in very large VLDL percentage	CPT1A LDLR DOCK7 BCAM PCSK9	9.93e-06	53	159	5	EFO_0022258
Disease	cholesterol to total lipids in very large VLDL percentage	CPT1A LDLR DOCK7 BCAM PCSK9	1.09e-05	54	159	5	EFO_0022244
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	CPT1A LDLR CES2 DOCK7 MACF1 BCAM PCSK9	1.37e-05	144	159	7	EFO_0004611, EFO_0020943
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	CPT1A LDLR RMI1 DOCK7 MACF1 BCAM PCSK9	1.78e-05	150	159	7	EFO_0004611, EFO_0020947
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	NRCAM CPT1A BIRC6 LDLR RMI1 DOCK7 MACF1 BCAM PCSK9	2.02e-05	276	159	9	EFO_0004612, EFO_0020943
Disease	cardiovascular disease	USP34 WAPL ATG7 THAP9 LDLR ADCY9 MEI4 KCNK3 DOCK7 PCNX1 PCSK9	4.04e-05	457	159	11	EFO_0000319
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	CPT1A LDLR CES2 RMI1 DOCK7 MACF1 BCAM PCSK9	5.49e-05	243	159	8	EFO_0004612, EFO_0020944
Disease	level of Sterol ester (27:1/18:1) in blood serum	LDLR ANKRD17 PCSK9	8.17e-05	16	159	3	OBA_2045195
Disease	cholesterol in medium VLDL measurement	LDLR DOCK7 BCAM PCSK9	9.32e-05	44	159	4	EFO_0022225
Disease	uterine fibroid	RAD18 SYNE1 PDLIM5 CDCA2 KANK1 ATM REV1	1.07e-04	199	159	7	EFO_0000731
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	CPT1A LDLR ASXL3 DOCK7 MACF1 BCAM PCSK9	1.11e-04	200	159	7	EFO_0004611, EFO_0020945
Disease	level of Sphingomyelin (d34:1) in blood serum	LDLR ANKRD17 PCSK9	1.18e-04	18	159	3	OBA_2045175
Disease	frontal fibrosing alopecia	NR2C1 TGFBR2 KIAA1217 SDK1	1.31e-04	48	159	4	EFO_0009855
Disease	cholesterol in medium LDL measurement	LDLR DOCK7 BCAM PCSK9	1.42e-04	49	159	4	EFO_0022224
Disease	cholesterol to total lipids in small VLDL percentage	LDLR DOCK7 BCAM PCSK9	1.67e-04	51	159	4	EFO_0022242
Disease	free cholesterol to total lipids in small HDL percentage	CPT1A LDLR BCAM PCSK9	1.67e-04	51	159	4	EFO_0022285
Disease	phospholipids in IDL measurement	LDLR DOCK7 BCAM PCSK9	1.80e-04	52	159	4	EFO_0022164
Disease	total lipids in medium LDL	LDLR DOCK7 BCAM PCSK9	1.80e-04	52	159	4	EFO_0022180
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	CPT1A LDLR CES2 DOCK7 MACF1 BCAM TASOR PCSK9	1.91e-04	291	159	8	EFO_0008317, EFO_0020946
Disease	triglycerides to total lipids in very large VLDL percentage	CPT1A LDLR BCAM PCSK9	1.94e-04	53	159	4	EFO_0022340
Disease	alpha fetoprotein measurement	USP34 RAD18 NCOR1 TET1 ANKRD17	2.13e-04	100	159	5	EFO_0010583
Disease	diffuse plaque measurement	MYT1L DCHS2 CAAP1 NEDD4L ANK2 NCAPG2 CRYL1 EYS MACF1 KIF4B DLEC1 TAFA5 C1orf94	2.48e-04	758	159	13	EFO_0010699
Disease	cognitive function measurement	USP34 CAAP1 NEDD4L MINPP1 THSD7B BIRC6 FAM135B FBXL4 MEI4 PLAA KIAA1217 PPA2 PAXIP1 RIMBP2 LTBP1 PRMT3 SDK1 LMNTD1 REV1	2.74e-04	1434	159	19	EFO_0008354
Disease	triglycerides to total lipids in small VLDL percentage	LDLR DOCK7 BCAM PCSK9	2.75e-04	58	159	4	EFO_0022338
Disease	Weaver syndrome	EED EZH2	2.85e-04	5	159	2	C0265210
Disease	Insulinogenic index measurement	MYCBP2 PPIP5K2	2.85e-04	5	159	2	EFO_0009961
Disease	total lipids in IDL	LDLR DOCK7 BCAM PCSK9	3.13e-04	60	159	4	EFO_0022161
Disease	cholesterol to total lipids in IDL percentage	LDLR MACF1 BCAM PCSK9	3.13e-04	60	159	4	EFO_0022233
Disease	RS-10-hydroxywarfarin to RS-warfarin ratio measurement	NEDD4L MEI4 ADGRE3 SIPA1L1 KIF4B	3.31e-04	110	159	5	EFO_0803335
Disease	free cholesterol in very large HDL measurement	LDLR DOCK7 BCAM PCSK9	3.55e-04	62	159	4	EFO_0022273
Disease	level of Sterol ester (27:1/18:2) in blood serum	LDLR ANKRD17 PCSK9	3.64e-04	26	159	3	OBA_2045194
Disease	triglycerides to total lipids in IDL percentage	LDLR DOCK7 BCAM PCSK9	3.78e-04	63	159	4	EFO_0022329
Disease	triglycerides to total lipids in medium VLDL percentage	LDLR DOCK7 BCAM PCSK9	3.78e-04	63	159	4	EFO_0022335
Disease	wheezing	RAD18 SLITRK1 PAX7 TAFA5	4.26e-04	65	159	4	EFO_0009715
Disease	beta-hydroxybutyric acid measurement	THSD7B KCNS3	4.27e-04	6	159	2	EFO_0010465
Disease	cholesterol to total lipids in very small VLDL percentage	LDLR DOCK7 BCAM PCSK9	4.78e-04	67	159	4	EFO_0022245
Disease	level of Sphingomyelin (d42:2) in blood serum	LDLR ANKRD17 PCSK9	5.06e-04	29	159	3	OBA_2045183
Disease	triglycerides to total lipids in very small VLDL percentage	LDLR DOCK7 BCAM PCSK9	5.34e-04	69	159	4	EFO_0022341
Disease	testosterone measurement	TRPM6 DCHS2 ANK2 MAP1A TPRN DLGAP4 LARP4 BIRC6 ADCY9 CDCA2 RMI1 HMCN1 PPA2 MACF1 KCNS3 RIMBP2 ZNF654	5.44e-04	1275	159	17	EFO_0004908
Disease	urate measurement, bone density	TRPM6 RAD52 SYNE1 MINPP1 THAP9 AKAP12 FBXL4 STRN EYS ADGRE3 KCNS3	5.59e-04	619	159	11	EFO_0003923, EFO_0004531
Disease	Epileptic encephalopathy	NEDD4L NUP214 PLAA	5.60e-04	30	159	3	C0543888
Disease	LDL cholesterol change measurement	LDLR PCSK9	5.95e-04	7	159	2	EFO_0007804
Disease	cholesteryl esters to total lipids in very small VLDL percentage	LDLR DOCK7 BCAM PCSK9	5.96e-04	71	159	4	EFO_0022259
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	HECTD4 CPT1A LDLR DOCK7 MACF1 BCAM PCSK9	5.96e-04	264	159	7	EFO_0008317, EFO_0020944
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	CPT1A LDLR MACF1 BCAM PCSK9	6.39e-04	127	159	5	EFO_0008595, EFO_0020947
Disease	docosahexaenoic acid measurement	CPT1A LDLR DOCK7 PCSK9 EPHA4	6.39e-04	127	159	5	EFO_0007761
Disease	esterified cholesterol measurement	LDLR DOCK7 ANKRD17 BCAM PCSK9	6.62e-04	128	159	5	EFO_0008589
Disease	free cholesterol to total lipids in small VLDL percentage	LDLR DOCK7 BCAM PCSK9	7.33e-04	75	159	4	EFO_0022287
Disease	coronary artery calcification	MYT1L NAAA CPT1A LDLR CRYL1 EYS SIPA1L1 DOCK7 BCAM	7.83e-04	450	159	9	EFO_0004723
Disease	Familial hypercholesterolemia	LDLR PCSK9	7.91e-04	8	159	2	cv:C0020445
Disease	free cholesterol measurement, low density lipoprotein cholesterol measurement	CPT1A LDLR ANKRD17 BCAM PCSK9	9.00e-04	137	159	5	EFO_0004611, EFO_0008591
Disease	level of Sphingomyelin (d36:1) in blood serum	ANKRD17 PCSK9	1.01e-03	9	159	2	OBA_2045178
Disease	emphysema imaging measurement	MYT1L MYCBP2 FAM135B RIMBP2 DLEC1	1.20e-03	146	159	5	EFO_0007626
Disease	free cholesterol:total lipids ratio, intermediate density lipoprotein measurement	CPT1A LDLR DOCK7 PCSK9	1.22e-03	86	159	4	EFO_0008595, EFO_0020945
Disease	familial hypercholesterolemia (is_implicated_in)	LDLR PCSK9	1.26e-03	10	159	2	DOID:13810 (is_implicated_in)
Disease	intermediate density lipoprotein measurement	LDLR DOCK7 BCAM PCSK9	1.28e-03	87	159	4	EFO_0008595
Disease	cholesterol in very small VLDL measurement	LDLR DOCK7 PCSK9	1.31e-03	40	159	3	EFO_0022231
Disease	free cholesterol in medium LDL measurement	LDLR BCAM PCSK9	1.31e-03	40	159	3	EFO_0022268
Disease	free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	CPT1A BIRC6 LDLR CES2 DOCK7 BCAM PCSK9	1.33e-03	303	159	7	EFO_0004612, EFO_0020945
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	CPT1A LDLR DOCK7 MACF1 BCAM PCSK9	1.33e-03	222	159	6	EFO_0008317, EFO_0020943
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	CPT1A LDLR CES2 MACF1 BCAM PCSK9	1.42e-03	225	159	6	EFO_0008317, EFO_0020947
Disease	sleep duration, low density lipoprotein cholesterol measurement	LDLR DOCK7 BCAM PCSK9	1.51e-03	91	159	4	EFO_0004611, EFO_0005271
Disease	Uterine leiomyoma	SYNE1 PDLIM5 KANK1 REV1	1.51e-03	91	159	4	HP_0000131
Disease	forced expiratory volume, body mass index	DIS3L2 HECTD4	1.54e-03	11	159	2	EFO_0004314, EFO_0004340
Disease	smoking status measurement	MYT1L NOL4 CAAP1 EED NOL6 HECTD4 XPO1 THSD7B BIRC6 INO80D DCAF5 RMI1 HECW2 DLEC1 SDK1	1.57e-03	1160	159	15	EFO_0006527
Disease	nasopharynx carcinoma (is_marker_for)	RAD52 EZH2 ATM	1.62e-03	43	159	3	DOID:9261 (is_marker_for)
Disease	free cholesterol to total lipids in very small VLDL percentage	LDLR DOCK7 PCSK9	1.62e-03	43	159	3	EFO_0022290
Disease	Neurodevelopmental Disorders	MYT1L ANK2 ASXL3 ZNF292	1.63e-03	93	159	4	C1535926
Disease	osteoarthritis, knee	ATG7 KIAA1217 LTBP1 PAX7 PCSK9	1.69e-03	158	159	5	EFO_0004616
Disease	social interaction measurement	THSD7B FBXL4 SIPA1L1 PPA2	1.70e-03	94	159	4	EFO_0009592
Disease	cholesteryl ester measurement, intermediate density lipoprotein measurement	LDLR DOCK7 BCAM PCSK9	1.70e-03	94	159	4	EFO_0008595, EFO_0010351
Disease	concentration of large LDL particles measurement	LDLR BCAM PCSK9	1.73e-03	44	159	3	EFO_0022160
Disease	diverticular disease	ADCY9 KIAA1217 KCNK3 DISP2 LTBP1 DLEC1	1.81e-03	236	159	6	EFO_0009959
Disease	lipid measurement, intermediate density lipoprotein measurement	LDLR DOCK7 BCAM PCSK9	1.84e-03	96	159	4	EFO_0004529, EFO_0008595
Disease	total lipids in very small VLDL measurement	LDLR DOCK7 PCSK9	1.85e-03	45	159	3	EFO_0022156
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	CPT1A LDLR DOCK7 MACF1 BCAM PCSK9	1.93e-03	239	159	6	EFO_0008317, EFO_0020945
Disease	epilepsy (implicated_via_orthology)	ANK2 NRCAM KCNT2 SCN7A KIF4B	1.94e-03	163	159	5	DOID:1826 (implicated_via_orthology)
Disease	total lipids in small LDL	LDLR BCAM PCSK9	2.09e-03	47	159	3	EFO_0022168
Disease	free cholesterol in small VLDL measurement	LDLR DOCK7 PCSK9	2.09e-03	47	159	3	EFO_0022272
Disease	free cholesterol in very small VLDL measurement	LDLR DOCK7 PCSK9	2.09e-03	47	159	3	EFO_0022275
Disease	free cholesterol in medium VLDL measurement	LDLR DOCK7 PCSK9	2.09e-03	47	159	3	EFO_0022269
Disease	spontaneous preterm birth	MYT1L KIAA1217 DLEC1 SDK1	2.21e-03	101	159	4	EFO_0006917
Disease	total lipids in lipoprotein particles measurement	LDLR DOCK7 PCSK9	2.22e-03	48	159	3	EFO_0022309
Disease	Mammary Neoplasms	RAD51C NRCAM SYNE1 CPT1A EZH2 AKAP12 TGFBR2 NCOR1 ATM	2.32e-03	527	159	9	C1458155
Disease	Agents acting on the renin-angiotensin system use measurement	ATG7 LDLR ADCY9 MEI4 KCNK3 PCNX1 TASOR	2.34e-03	335	159	7	EFO_0009931
Disease	phospholipids in medium LDL measurement	LDLR BCAM PCSK9	2.36e-03	49	159	3	EFO_0022183
Disease	apolipoprotein B to apolipoprotein A1 ratio	LDLR BCAM PCSK9	2.36e-03	49	159	3	EFO_0021897
Disease	cholesterol in small LDL measurement	LDLR BCAM PCSK9	2.36e-03	49	159	3	EFO_0022227
Disease	cholesteryl esters to total lipids in small VLDL percentage	LDLR DOCK7 PCSK9	2.36e-03	49	159	3	EFO_0022256
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	LDLR MACF1 BCAM PCSK9	2.37e-03	103	159	4	EFO_0008595, EFO_0020944
Disease	triglycerides to total lipids in medium LDL percentage	LDLR BCAM PCSK9	2.50e-03	50	159	3	EFO_0022334
Disease	free cholesterol in LDL measurement	LDLR BCAM PCSK9	2.50e-03	50	159	3	EFO_0022266
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	LDLR ANKRD17	2.52e-03	14	159	2	EFO_0004611, EFO_0008589
Disease	obsolete_red blood cell distribution width	KIAA0232 MYO19 HECTD4 EZH2 BIRC6 ZFAND4 ADCY9 CDCA2 STRN GTF2IRD2B RESF1 HECW2 KIAA1217 GTF2IRD2 AKAP13 SMIM1	2.59e-03	1347	159	16	EFO_0005192
Disease	familial hyperlipidemia	LDLR DOCK7 BCAM PCSK9	2.63e-03	106	159	4	MONDO_0001336
Disease	free cholesterol in large LDL measurement	LDLR BCAM PCSK9	2.65e-03	51	159	3	EFO_0022176
Disease	triglycerides to total lipids in large LDL percentage	LDLR BCAM PCSK9	2.65e-03	51	159	3	EFO_0022331
Disease	disease recurrence, colon carcinoma	TPRN THSD7B MACF1	2.65e-03	51	159	3	EFO_0004952, EFO_1001950
Disease	phospholipids in very small VLDL measurement	LDLR DOCK7 PCSK9	2.65e-03	51	159	3	EFO_0022300

Protein segments in the cluster

Peptide	Gene	Start	Entry
TSLAERATADTCQSI	C2orf16	911	Q68DN1
TAEDLASSCSSNTVV	CTTNBP2NL	611	Q9P2B4
VELESEISTTADDCS	AKAP9	101	Q99996
LSSSSSVFVRCDEER	BIRC6	4591	Q9NR09
ESSELVTTCQAETLA	AKAP12	1131	Q02952
KLCDNIVSESESTTA	AKAP13	681	Q12802
RTETVRSCTTESCDF	CPT1A	601	P50416
SQQDICIDSASSVRE	CAAP1	221	Q9H8G2
ATSLAETIDNCDSSL	DRD1	176	P21728
SRQDCDSATSTVTDI	C1orf94	196	Q6P1W5
DSATSTVTDILCAAE	C1orf94	201	Q6P1W5
SSVSCALDEAAAALT	ANKRD17	206	O75179
KDETTCISQDTRALS	DIS3L2	211	Q8IYB7
VLSNRSSCLDTTQAD	DISP2	346	A7MBM2
SSCLDTTQADAARTL	DISP2	351	A7MBM2
ACSEAESTAAETLDL	DLGAP4	486	Q9Y2H0
VRAALSCSDSVAVTD	ASXL3	1391	Q9C0F0
TFTEADQTSRDVSCV	ANO8	271	Q9HCE9
DSDSINALCTQISSS	NUMBL	356	Q9Y6R0
TCSSSKTAREDLESV	CHML	511	P26374
FRDTVVTSACSLQTE	RAD51C	346	O43502
ETTSTECRQDVATNL	RASA4	296	O43374
EVSREKSSNCAASTE	NR2C1	191	P13056
RVSSRSHTEEDCTEE	UQCRH	56	P07919
ETTSTECRQDVATNL	RASA4B	296	C9J798
SDLQSTRCVSAQEAE	RAB42	131	Q8N4Z0
TRCVSAQEAEELAAS	RAB42	136	Q8N4Z0
SSSCIDIQEVLSSSE	RAD18	421	Q9NS91
DQDCSSRSLSSSAVE	RAD52	236	P43351
ATSISASCSQRADSI	PAX7	416	P23759
EDAALDCSVNSRTSE	BEND3	26	Q5T5X7
LRSGTCTRDESSVQS	ANK2	1566	Q01484
SLTDCIGTVDSRAES	CHMP5	16	Q9NZZ3
TQLSSVDTRCSSLES	HECW2	651	Q9P2P5
GITACLSQVSSEDRS	PAXIP1	101	Q6ZW49
TSISDDNSASLRCEN	TRAF3IP1	396	Q8TDR0
TRFTAGVICSETASD	LOXL3	516	P58215
AEEEHVSSATSITEC	MAP1A	821	P78559
ADSLRELSQTCATCS	EYS	1546	Q5T1H1
CVANTTLDSVSASAV	NRCAM	616	Q92823
SEESFGRTLQCTSVS	LRIT2	31	A6NDA9
ESSVFCTSIVAQDSR	NAAA	121	Q02083
LVSVINSSICADTDS	MYO19	391	Q96H55
TDLSTDLESQLSVSC	EDRF1	796	Q3B7T1
RDLSTSDTCVEQSHS	KCNK3	331	O14649
ITSASVDSAICQLSE	ARRDC5	316	A6NEK1
SDTDEIAATCTINEN	FANCM	901	Q8IYD8
DSCSLHSQTLSEDER	HPS5	466	Q9UPZ3
ADTSSLVEVRGSCVN	EPHA4	221	P54764
KDETSSSSEANSRCQ	EZH2	401	Q15910
VDQSLSSACDTEVAS	PCNX1	251	Q96RV3
DNTCVVRSRDVSTTG	PCSK9	651	Q8NBP7
QAAVQCLRSASDESS	KIAA0232	111	Q92628
QCRSRTSTDLDVDVD	LTBP1	1326	Q14766
STVVANLSACDQVDS	CES2	271	O00748
DNRLFATCSDDTTIA	DCAF10	221	Q5QP82
EELDSTDTSVVISSC	KIF21B	1011	O75037
TDTSVVISSCSLAEA	KIF21B	1016	O75037
DACAATSTRAITSAQ	KIF21B	1396	O75037
VVLDSCEVSTENDQS	KIF20B	1601	Q96Q89
TSSTGEEALVAAVRC	NOL6	651	Q9H6R4
CDTSSARQESTSKAD	OBI1	321	Q5W0B1
QSDDSEERSLETICA	DCAF5	816	Q96JK2
IQDSSCEASSELREN	KANK1	381	Q14678
VRASRDCASISSEDS	LAX1	176	Q8IWV1
SQSLESEDARTSCKD	NUP214	991	P35658
TVGSCSRVENSLDAS	LMNTD1	71	Q8N9Z9
VDRSSESVTCQTFEL	TUBGCP5	671	Q96RT8
TSFSRDSSILIAVCD	EED	416	O75530
SSIEDNEDICNTTSL	KCNS3	471	Q9BQ31
SRCEVDRTSSDHQTI	KCNT2	386	Q6UVM3
TVAIDLQDTSCRSAS	KCNT2	596	Q6UVM3
ADTSSIQTCDLLSDQ	KCNT2	636	Q6UVM3
SRESGAACTDAEITV	PGAP6	86	Q9HCN3
SVCSETSQELAEGQR	PDLIM5	211	Q96HC4
ACTVRAQESSEDVSG	HECTD4	756	Q9Y4D8
STSCLDSEEIRENQG	MACF1	2931	Q9UPN3
VREGTSVSLECESNA	HMCN1	3071	Q96RW7
STTTILCTVEDENDH	DCHS2	1811	Q6V1P9
ASATLSCEVAQAQTE	OBSCN	906	Q5VST9
EDLNALSDSACSVSV	PIKFYVE	231	Q9Y2I7
SSEITNSETLVRCSR	ATM	706	Q13315
QLDCSIVSRSSQDSR	IGSF3	971	O75054
RNSAECVSEDDTTES	ICE1	386	Q9Y2F5
TNERSSASDCISSSE	GRID2IP	721	A4D2P6
DSTRDRTLDQQCTVS	ATG7	561	O95352
ESTIRCTSNDQERGT	CR2	571	P20023
SLERTTSGDDACNLT	DOCK7	446	Q96N67
CREAAVSASDILQES	CUSTOS	161	Q96C57
TCSSSTSVIADLQED	PRMT3	201	O60678
ETVLSNEISTLSTSC	GJA9	326	P57773
TANRSVCDTDIDELA	FBXL4	541	Q9UKA2
DASTIEIHTASESCN	GPR143	376	P51810
NEDCQTSRALSSFIS	GUCY2F	101	P51841
EVSCDSSGDSNSVRV	ADCY9	16	O60503
CETTRNTTGIEESTD	LARP4	76	Q71RC2
TDRACAVETSVDLSE	CDCA2	231	Q69YH5
DDDAESRSSRVTQLC	INO80D	361	Q53TQ3
LSDETVACTAAAIDT	KIF4B	476	Q2VIQ3
SIIDDRVILSSSTSC	CRYL1	111	Q9Y2S2
VTATQSNICDEDSAT	JCHAIN	106	P01591
ELSCTSAADAINRNS	FAM135B	936	Q49AJ0
EQSEATSKDCSRLTN	WTAP	261	Q15007
VTDAERSIVSPSESC	GTF2IRD2	196	Q86UP8
VTDAERSIVSPSESC	GTF2IRD2B	196	Q6EKJ0
VTSALSRDGISCEAS	BCAM	511	P50895
AITISKESSDCSTEQ	DLEC1	1076	Q9Y238
ESQVLATSCAAEAAS	DUSP4	331	Q13115
TEERVGSSSSESCAQ	SCAF11	466	Q99590
NRSVVAGSSETTLEC	SDK1	301	Q7Z5N4
AGSSETTLECIASAR	SDK1	306	Q7Z5N4
SSSSSDCRETEELVG	PPP4R2	371	Q9NY27
SDIFASCRNVIDVTS	OTOGL	1141	Q3ZCN5
RNSATCHSEDSDLEI	PDCL	286	Q13371
GTISVSDDRAEQRTC	NR6A1	46	Q15406
RTESSDLSQHFVESC	MEI4	111	A8MW99
CSISSEENTDDNITV	PLEKHA8P1	136	O95397
AAGTCEIVTLDRDSS	TAFA5	41	Q7Z5A7
ISVQCVTSRGSSDEL	RIMBP2	366	O15034
LTLESNVDTTANSSC	STRN	651	O43815
RQTGSSAEITCDLAE	TRGV2	31	A0A075B6R0
SSEQRTSCRATADQL	SYNE1	1941	Q8NF91
LQDSPEERVTTSCSD	NBPF7P	316	P0C2Y1
EERVTTSCSDHDVSQ	NBPF7P	321	P0C2Y1
EERENSACLLASSES	PWWP3B	146	Q5H9M0
ELTANNDTSSERCFT	RMI1	256	Q9H9A7
TANDTCSSAAIQEDI	RESF1	1006	Q9HCM1
VSEAEFLARTACTSV	MTERF4	296	Q7Z6M4
RASNASITVEECLAA	PNMA3	221	Q9UL41
REERDVSQCESVAST	NCOR1	691	O75376
KESSRSSQEIETSSC	SIPA1L1	91	O43166
KALVDTSCSSNRDSV	KIAA1217	1686	Q5T5P2
EDDRSDISSTCANNI	TGFBR2	221	P37173
RQTGSSAEITCDLTV	TRGV3	31	P03979
ENLHSEVVEVCTSST	MYCBP2	2926	O75592
DATESTARVELHSTC	SUPT5H	726	O00267
VSLGAVSSTEEASRC	SMIM1	21	B2RUZ4
RCTQEEARSLVESVS	PPA2	301	Q9H2U2
SAVAESILASACESE	NOL4	486	O94818
SILASACESESRNAA	NOL4	491	O94818
RTSIDIVCSEGENSN	TASOR	1571	Q9UK61
DEESEQRTASLLNSC	TET1	916	Q8NFU7
GSTVVCTLTREDNRS	TET1	1681	Q8NFU7
SELVNETVSACSRNA	AKAP3	176	O75969
SVAIETQAITDNCSE	ADGRE3	191	Q9BY15
TSSVSCALDEAAAAL	ANKHD1	176	Q8IWZ3
SCSGTVSEQLRNSET	CMKLR2	331	P46091
ELAFDTSSADVRCSV	NCAPG2	426	Q86XI2
NLTVSSATCHDTIDD	CYSLTR1	6	Q9Y271
FENSLSTECIIRSAS	USP53	891	Q70EK8
SNHRDSESITDVCSN	TRAK2	21	O60296
TTQSEITDLSSASCL	TRAK2	536	O60296
ETTESQVKDSSLCVS	TMF1	146	P82094
SDIVGASRTSESLCQ	XPO1	151	O14980
RSCTSDTKEAATQED	UTP14C	376	Q5TAP6
DNSTRSAQSSECSEV	TRPM6	1501	Q9BX84
TSEECELARANSTSD	MINPP1	471	Q9UNW1
SSASEINSLQTVCDS	SLITRK1	656	Q96PX8
AVDLEISSASRTCTF	REV1	876	Q9UBZ9
SAVGCSTRDTVLSRE	THAP9	6	Q9H5L6
EACTSGQLVVASRES	TBC1D16	316	Q8TBP0
SETEFLSCANDASIR	PLAA	201	Q9Y263
SDTCVSESNDNSRTT	ZNF292	2451	O60281
QEVTALEEINCSSSS	ZNF654	611	Q8IZM8
STNRIVEDDASISSC	WAPL	146	Q7Z5K2
RQTGSSAEITCDLAE	TRGV4	31	A0A0C4DH28
EASTSALRESCQAEH	TACC2	1171	O95359
TCDRVSTTVETFQDL	USP20	461	Q9Y2K6
CVSAATSTNDSFEIR	TPRN	286	Q4KMQ1
DAEVTACSITSVLSQ	USP17L8	351	P0C7I0
SSECSTVDIAISEEE	SCN7A	871	Q01118
SNSTRICNLTEEESS	USP34	126	Q70CQ2
DVCNNESLVSDTETS	USP34	346	Q70CQ2
RVSSDEEHTVDSCIS	USP34	3356	Q70CQ2
DSDSDSLSSCQQRVK	PPIP5K2	606	O43314
EDALVTTCNSISSVS	WDR89	206	Q96FK6
QTRAVSCISDDNRSA	THSD7B	831	Q9C0I4
DVQNITDSSFSRTTC	ZFAND4	511	Q86XD8
DCRSNLETESSHQSV	TUT4	851	Q5TAX3
CLTEAEAAVATQETS	LDLR	711	P01130
SCDVSKSSQASDRVL	MYT1L	591	Q9UL68
SRLRSCSVTDAVAEQ	NEDD4L	336	Q96PU5